Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB, Antabio, Astrazeneca, BMS, Cabaletta, Immunicum, Interna, Kiadis, Laurent, Medivir, Pulmotect, Zia.
Biopharmas raising money in public or private financings, including: Aptose, Algernon, Delcath, Kura, Mind Medicine, Nascent, Oncology Venture, TG, Trillium.